Delivered 41% revenue growth and 83% gross margin in Q4 2025; Improved Net Loss by 52% and achieved first-ever Adjusted EBITDA positivity in Q4 2025; FY2026 Revenue Guidance of $106-112 million, mid-p ...
Personalis (NASDAQ:PSNL) executives on the company’s fourth quarter 2025 earnings call highlighted accelerating clinical adoption of its ultra-sensitive NeXT Personal minimal residual disease (MRD) ...
In Colorado, as of 2025, about 500 people a year die from lung cancer as the result of radon gas exposure. Nationally, the number of lung cancer deaths attributed to radon is about 21,000 per year.
Thermo Fisher Scientific is launching a new test it says can help doctors avoid the “trial-and-error” approach typically used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results